glucose-6-phosphate-dehydrogenase-deficiency-diagnostic-algorithm.pdf
© Mayo Foundation for Medical Education and Research (MFMER). All rights reserved. Glucose-6-Phosphate Dehydrogenase (G6PD) Deficiency Diagnostic Algorithm * If patient status is post-allogeneic stem cell transplant (HSCT), testing can...
MCL Electron Microscopy Procedures of Handling Specimens for Electron Microscopy MC1235170
MCL Electron Microscopy Procedures Handling Specimens Electron Microscopy Electron Microscopy Procedures Handling Specimens Electron Microscopy EM Electron Microscopy Varies Specimen specimen representative
Lysosomal metabolism and storage disorders - Insights
Learn more about how Mayo Clinic Laboratories’ comprehensive menu of biochemical and molecular testing can clarify diagnosis of a lysosomal metabolism and storage disorder.
Membranous nephropathy - Insights
Membranous nephropathy (MN) is one of the leading causes of nephrotic syndrome in adults. Our menu of clinically validated assays assists with diagnosis, monitors disease progression, and guides clinical outcomes.
Find out how our kidney stone services identify the physical compositions of stones to help optimize care for patients with nephrolithiasis.
Live and virtual meetings featuring general sessions, breakouts, panel discussions, and case studies, led by laboratory leaders and health care industry experts.
Register now for Phlebotomy 2024: Pathways to Excellence - Insights
Secure your spot at our Phlebotomy 2024 virtual conference on April 17–19, 2024. Tailored for phlebotomists, phlebotomy managers, phlebotomy educators, and patient care staff, this event offers exclusive insights, live case discussions, and...
MayoComplete next-generation sequencing: Transforming comprehensive cancer care - Insights
Offering increased sensitivity and improved accuracy, MayoComplete next-generation testing ensures health care providers understand the distinctive genetic features of their patients’ cancer to make informed decisions to guide their care.
Alzheimer's Disease Testing - Mayo Clinic Laboratories
We have developed an innovative evaluation for Alzheimer's disease, which uses CSF biomarkers to achieve a high concordance with amyloid PET scan.
MCL Familial Chromosomal Microarray FISH Testing Information MC1235236
MCL Familial Chromosomal Microarray FISH Testing Information Family Member Phenotype Information Genomic Testing Instructions accurate interpretation reporting familial genetic results highly contingent